title: LH subunit mRNA concentrations during LH surge in ovariectomized estradiol-replaced rats.
abstract: In cycling rats, pituitary concentrations of luteinizing hormone (LH) beta-subunit mRNA increase two- to threefold before the afternoon proestrus LH surge without a corresponding increase in alpha-subunit mRNA. Estradiol (E2) treatment is known to allow expression of daily LH surges in ovariectomized (OVX) rats, and the timing, magnitude, and duration of LH secretion is similar to the LH surge on proestrus. The present study was conducted to examine whether the regulation of LH subunit mRNAs during the LH surge in OVX-E2-treated rats is similar to that present on proestrus. Female Holtzman rats were OVX and Silastic implants containing E2 were inserted subcutaneously under ether anesthesia. Some animals received bromocriptine (0.6 mg sc, twice/day beginning 1 h before surgery). On the 2nd day after surgery, groups of animals (n = 4-10/group) were decapitated at intervals between 1000 and 2100. LH and prolactin (PRL) levels were measured in trunk blood. LH subunit mRNA concentrations in the pituitaries were measured by dot-blot hybridization assay. In OVX-E2 rats the LH surge occurred at 1830 and was accompanied by a selective twofold increase in alpha-subunit mRNA (from 266 +/- 18 to 459 +/- 61 pg cDNA bound/100 micrograms pituitary DNA) and maximum values were present at 1730. LH beta-subunit mRNA (m = 29 +/- 1 pg cDNA bound/100 micrograms pituitary DNA) was unchanged throughout the day. Bromocriptine treatment resulted in the suppression of serum PRL (m = 23 +/- 2 ng/ml) and the LH surge was delayed by 1-1.5 h and somewhat blunted.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.
authors.forename: D J
authors.initials: DJ
authors.lastname: Haisenleder
authors.forename: A L
authors.initials: AL
authors.lastname: Barkan
authors.forename: S
authors.initials: S
authors.lastname: Papavasiliou
authors.forename: S M
authors.initials: SM
authors.lastname: Zmeili
authors.forename: C
authors.initials: C
authors.lastname: Dee
authors.forename: M L
authors.initials: ML
authors.lastname: Jameel
authors.forename: G A
authors.initials: GA
authors.lastname: Ortolano
authors.forename: M R
authors.initials: MR
authors.lastname: el-Gewely
authors.forename: J C
authors.initials: JC
authors.lastname: Marshall
mesh_terms: D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D002940:Circadian Rhythm; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007986:Luteinizing Hormone / Q000145:classification / Q000235:genetics* / Q000378:metabolism; D009994:Osmolar Concentration; D010052:Ovariectomy; D010902:Pituitary Gland / Q000378:metabolism; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats
chemical_list: D012333:RNA, Messenger; D001971:Bromocriptine; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone